Cellogen Blog | Insights into Gene and Cell Therapy

Blogs

Home > Blogs

Building AI That Actually Helps People: CAR-T AI Agent at Cellogen Therapeutics

Building AI That Actually Helps Peopl...

Some days, everything works...

Shivanshu Mishra

Leveraging AI to Design the Next Generation of Genome Editing Proteins: My Journey from Data to Design

Leveraging AI to Design the Next Gene...

I started doing work in bio...

Engineered Viral Vectors for In Vivo Gene Therapy Introducing “viroVbots” and the Next Wave of Innovation

Engineered Viral Vectors for In Vivo ...

Lentiviral vectors are now ...

Shaikh Nisar Rahim

How Structure-Driven Nanobody Design Is Shaping Cancer Therapeutics

How Structure-Driven Nanobody Design ...

As a structural bioinformat...

Why Protein Purification is so Important in Building the Next Generation of Car-T Therapies

Why Protein Purification is so Import...

CAR-T cell therapy has tran...

Where Living Cells Become Living Cures: Inside the Science of CAR T Manufacturing

Where Living Cells Become Living Cure...

When I first stepped into a...

From Atoms to Algorithms: AI in Structural Bioinformatics

From Atoms to Algorithms: AI in Struc...

As a structural Bioinformat...

Beyond Code: My Path as an AI Scientist

Beyond Code: My Path as an AI Scientist

Being an AI scientist is ra...

Nisha Chaudhary

In Vivo Lentiviral CAR T Therapy: A New Frontier in Treating Autoimmune Diseases

In Vivo Lentiviral CAR T Therapy: A N...

Autoimmune diseases are pre...

CAR T cells were just the beginning. The real revolution is harnessing the potential of the entire immune orchestra

CAR T cells were just the beginning. ...

Cell Therapies Beyond the C...

Phage Display for Finding Antibodies: The Next Step in Targeted Therapies

Phage Display for Finding Antibodies:...

Phage Display is a technolo...

Aparna Ramachandran

Rewriting the Future of Sickle Cell Disease: How Genome Editing Offers New Hope

Rewriting the Future of Sickle Cell D...

“A person living with sickle cel...

Aswathi C Bhaskaran

AI-Guided CAR Design and AKT3 Degradation Synergize to Enhance Bispecific and Trispecific CAR-T Cell Persistence and Overcome Antigen Escape

AI-Guided CAR Design and AKT3 Degrada...

The structural design of ch...

Computational science in drug discovery

Computational science in drug discovery

Computational science is tr...

Beyond Blood Cancers: The Future of CAR-T Therapy in Solid Tumors

Beyond Blood Cancers: The Future of C...

CAR-T cell therapy has re...

How we can treat Sickle Cell Disease, Thalassemia and other Blood Disorders with Gene manipulation

How we can treat Sickle Cell Disease,...

Sickle cell disease (SCD)...

CAR T-Cell Therapy: A New Frontier in Treating Solid Tumors

CAR T-Cell Therapy: A New Frontier in...

Chimeric Antigen Receptor (...

CRISPR-Cas is revolutionising Blood Cancer Treatment

CRISPR-Cas is revolutionising Blood C...

Blood cancers, including le...

CAR T-Cell Therapy: A New Frontier in Treating Solid Tumors

CAR T-Cell Therapy: A New Frontier in...

Cancer remains a significan...